-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Relatlimab in Non-Hodgkin Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Relatlimab in Non-Hodgkin Lymphoma Drug Details: Relatlimab (BMS-986016) is under development for the treatment of...
-
Sector Analysis
![]()
India Power Market Outlook to 2035 – Market Trends, Regulations and Competitive Landscape
India Power Market Report Overview The annual power consumption in India was 1,214TWh in 2022. It is expected to grow at a CAGR of more than 6% during 2022-2035, backed by an increase in consumption from the industrial and residential sectors. India Power Market Outlook (2022-2035) Buy the Full Report for More Insights on the India Power Market Forecast, Download a free Report Sample The India power market research report discusses the power market structure of India and provides historical...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ZL-1211 in Adenocarcinoma Of The Gastroesophageal Junction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ZL-1211 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: ZL-1211 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Bempedoic Acid Sr in Non-Alcoholic Steatohepatitis (NASH)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Bempedoic Acid Sr in Non-Alcoholic Steatohepatitis (NASH)Drug Details:Bempedoic acid SR is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Branebrutinib in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Branebrutinib in Rheumatoid Arthritis Drug Details:Branebrutinib (BMS-986195) is under development for the treatment of moderate to...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TAA-Specific CTLs in Multiple Myeloma (Kahler Disease)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TAA-Specific CTLs in Multiple Myeloma (Kahler Disease) Drug Details: Tumor Associated Antigen (TAA) specific cytotoxic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RD-138 in Plasma Cell Neoplasm
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RD-138 in Plasma Cell Neoplasm Drug Details: RD-138Â is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy to Target HER-2 for Oncology in Metastatic Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cellular Immunotherapy To Target Her-2 For Oncology in Metastatic Breast Cancer Drug Details:Cellular immunotherapy is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rocatinlimab in Atopic Dermatitis (Atopic Eczema)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Rocatinlimab in Atopic Dermatitis (Atopic Eczema) Drug Details: Rocatinlimab is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RLYB-116 in Myasthenia Gravis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RLYB-116 in Myasthenia Gravis Drug Details:RLYB-116 is under development for the treatment of paroxysmal nocturnal hemoglobinuria...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Colorectal Cancer Drug Details: Decoy-20 is under development for the treatment of solid...
-
Thematic Analysis
New![]()
Metaverse – Thematic Intelligence
How is our ‘Metaverse - Thematic Intelligence’ report different from other reports in the market? The report provides a comprehensive overview of one of the most talked-about themes of the last few years. The comprehensive value chain looks at all aspects of the metaverse theme. It covers foundational technologies like semiconductors and blockchain, highlights tools like artificial intelligence (AI) that are prerequisites for a successful metaverse ecosystem, discusses the hardware used to access the metaverse, and analyzes the core metaverse...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LGK-974 in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LGK-974 in Triple-Negative Breast Cancer (TNBC) Drug Details: LGK-974 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Goflikicept in Pericarditis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Goflikicept in Pericarditis Drug Details: Goflikicept is under development for the treatment of idiopathic recurrent pericarditis,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RG-6115 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RG-6115 in Gastric Cancer Drug Details:RG-6115 (RO-7119929) is under development for the treatment of solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PMUC1CALLO-1 in Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PMUC1CALLO-1 in Colorectal Cancer Drug Details:P-MUC1CALLO-1 is under development for the treatment of solid tumors derived...
-
Sector Analysis
![]()
India Biopower Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
India Biopower Market Report Overview The cumulative installed capacity for biopower in India was 10,965.4 MW in 2022. It is expected to achieve a CAGR of more than 1% during 2022-2035. The India Biopower market research report offers comprehensive information and an understanding of the biopower market in India. The report discusses the renewable power market in the country and provides forecasts up to 2035. India Biopower Market Outlook, 2022-2035 (MW) Buy Full Report for More Insights on the India...
-
Sector Analysis
![]()
India Solar Thermal Power Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
India Solar Thermal Power Market Report Overview The cumulative installed capacity for solar thermal power in India was 232.5 MW in 2022 and is expected to achieve a CAGR of more than 2% during 2022-2035. India Solar Thermal Power Market Outlook, 2022-2035 (MW) Buy Full Report for More Insights into India Solar Thermal Power Market Market Forecast Download a Free Report Sample The India solar thermal power market research report offers comprehensive information and understanding of the solar thermal power...
-
Product Insights
![]()
SUEZ Recylg and Rec UK – Benedict Wharf Waste Site Residential Community – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our SUEZ Recylg and Rec UK - Benedict Wharf Waste Site Residential Community - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Inobrodib in Refractory Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Inobrodib in Refractory Multiple Myeloma Drug Details: Inobrodib (CCS-1477) is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.